* Pulse Biosciences Inc PLSE.OQ PLSE.O is expected
to show a
fall in quarterly revenue when it reports results on November
10.
* The Hayward California-based company is expected to
report a
65.2% decrease in revenue to $200 thousand from $574 thousand a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Pulse Biosciences
Inc is
for a loss of 45 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
This summary was machine generated November 9 at 03:04 GMT. All
figures in US dollars unless otherwise stated